1 / 14

Access to Medicine Index Methodology Changes Between Index 2008 & Index 2010

Access to Medicine Index Methodology Changes Between Index 2008 & Index 2010. Access to Medicine Index Methodology Structural Changes for Index 2010. Index 2008. ATM Management. Public Policy & Advocacy. R&D. Patents & Licensing. Equitable Pricing. Capacity. Donations. Philanthropy.

ondrea
Télécharger la présentation

Access to Medicine Index Methodology Changes Between Index 2008 & Index 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Access to Medicine Index Methodology Changes Between Index 2008 & Index 2010

  2. Access to Medicine Index Methodology Structural Changes for Index 2010 Index 2008 ATM Management Public Policy & Advocacy R&D Patents & Licensing Equitable Pricing Capacity Donations Philanthropy 3

  3. Access to Medicine Index Methodology Evolves in-line with Global Health Environment • To adjust methods to changing global healthcare priorities • To improve methodology based on learning from past indices Stakeholder Review & Methodology Update Process Index 2010 2012 Index 2008 Significant Changes Incremental Changes

  4. Data Collection Process Where Does Our Data Come From? Third-Party Sources Databases: Factiva/Lexis NexusMulitlateral / G’ment Reports Civil Society / NGO Reports Academic Literature Interviews with Partners (iNGO’s, PDPs, patent pool, donation orgs etc) Media Databases (Index Country media) Company Originated Company Annual Report / SEC filings Company CSR / Sustainability Docs Company Websites / pages Qualitative Questionnaire Excel: R&D Pipeline Excel: Product Portfolio Index Database

  5. Index Structure: strategic drivers Commitments • Indicator of future performance • Robustness (detailed? with clear goals? Supported by operational targets?) • Policy Stances – publicly available?

  6. Index Structure: strategic drivers Transparency • Improving accountability to stakeholders (focus on public disclosure and quality of disclosure) • Facilitate learning – focus on process disclosure • Improve internal company (and sector-wide) reporting

  7. Index Structure: strategic drivers Performance • “Ideally”, capturing the impact of companies on health burden “on the ground”. • Remains to be the focus area of the Index for improvement & will gradually improve over time

  8. Index Structure: strategic drivers Business Model Innovation • Focus on business model Innovation (‘new approaches’) • Uniqueness • Promise of impact or realised impact • Key strategic pillar for learning

  9. Index Structure: Seven Technical Areas Each area has 2–3 sub-topics of focus • For example: • Advocacy and Lobbying • Competition Behavior • Marketing Behavior • For example: • Innovative R&D • Adaptive R&D • Intellectual Property Sharing

  10. Access to Medicine Index Methodology Issue Focus of Technical Areas 12

  11. Data Analysis ProcessThe bigger picture For the analysis of all companies we always focus on the depth and breadth of the companies ‘access’ initiatives: All approved products targeting Index Diseases – not just the flagship programmes(portfolio analysis) All areas of R&D activity for eligible areas (pipeline analysis) It is a relative index. Score of 5 indicates leading practice compared with peers, score of zero indicates lagging practice and 2.5 aims to reflect average practice. 13

  12. 14

More Related